A randomised controlled trial to determine the cost-effectiveness of fluoxetine for mild to moderate depression with somatic symptoms in primary care

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2003
This article has no abstract
Epistemonikos ID: f9f625c2ff33cee6057234be9a92ea332b2590ac
First added on: Jan 18, 2025